Related Experiment Video
Updated: Jul 6, 2026
08:12
Intramyocardial Cell Delivery: Observations in Murine Hearts
Published on: January 24, 2014
Cellular replacement therapy for arrhythmia treatment: early clinical experience
1Department of Cardiology, Athens Euroclinic, 9 Athanassiadou Street, Athens 11521, Greece. dkatritsis@euroclinic.gr
Summary
Skeletal myoblast transplantation may cause heart rhythm problems after myocardial infarction. However, mesenchymal stem cell therapy might reduce arrhythmias by improving scar tissue, though more clinical data is needed.
Area of Science:
- Cardiovascular Research
- Regenerative Medicine
- Stem Cell Therapy
Background:
- Skeletal myoblast transplantation is known to potentially cause proarrhythmia in infarcted myocardium.
- Evidence regarding proarrhythmia from bone marrow-derived stem cells, especially mesenchymal stem cells (MSCs), is inconclusive.
- Preliminary data suggests MSCs may have anti-arrhythmic effects via myocardial scar remodeling.
Purpose of the Study:
- To evaluate the arrhythmogenic potential of stem cell transplantation for myocardial repair.
- To investigate the potential anti-arrhythmic effects of mesenchymal stem cells.
- To summarize current evidence on stem cell therapy for post-infarction arrhythmias.
Main Methods:
- Review of clinical and experimental studies on stem cell transplantation for infarcted myocardium.
- Analysis of data concerning proarrhythmia and anti-arrhythmic effects.
- Assessment of evidence on mesenchymal stem cell impact on myocardial scar remodeling.
Main Results:
- Skeletal myoblast transplantation is associated with a proarrhythmic risk.
- The arrhythmogenic potential of bone marrow-derived stem cells, including MSCs, remains uncertain.
- Experimental and preliminary clinical data suggest a potential anti-arrhythmic benefit of MSCs through scar modulation.
Conclusions:
- While skeletal myoblasts carry a proarrhythmic risk, MSCs may offer an anti-arrhythmic advantage.
- Further clinical studies are required to confirm the safety and efficacy of MSC transplantation for managing post-infarction arrhythmias.
- Mesenchymal stem cell therapy holds promise for improving myocardial repair and reducing cardiac arrhythmias.
More Related Videos
09:11Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
Published on: September 22, 2014
08:24Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
Published on: May 25, 2020
Related Concept Videos
01:29Disturbances in Heart Rhythm
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
01:25Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:28Mechanism of Cardiac Arrhythmias
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...